Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06586021 · ClinicalTrials.gov registry record · NA
Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall
A NA study of Abdominal Aortic Aneurysm (AAA), sponsored by Endoron Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06586021 is a NA study of Abdominal Aortic Aneurysm (AAA) that is actively recruiting participants, run by Endoron Medical. The registered enrollment target is 25 participants, below the 180-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06586021, a NA study of Abdominal Aortic Aneurysm (AAA), is actively recruiting participants, sponsored by Endoron Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
Conditions Studied
Interventions
- DEVICE Aortoseal Endostapling System
Study Locations (1)
Virginia
- Sentara Health Research Center - Norfolk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-02-06 |
| Est. Completion | 2029-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06586021
The ClinicalTrials.gov registry entry for NCT06586021 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 180-participant average among 3 other Abdominal Aortic Aneurysm (AAA) trials with a reported enrollment target (86% lower). The listed sponsor is Endoron Medical, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm (AAA) appearing as the primary indexed condition, and to 1 intervention - of which Aortoseal Endostapling System is the first listed.
NCT06586021 reports 1 study location spanning 1 distinct geographic area - top geographies include Virginia.
Frequently Asked Questions
What is clinical trial NCT06586021 about?
NCT06586021 is a clinical study titled "Evaluation of the Aortoseal™ for Sealing and Fixation of AAA Endovascular Grafts to Aortic Wall". The Aortoseal Endostapling System is indicated in patients undergoing, or having undergone, treatment of an abdominal aortic aneurysm (AAA) with an endovascular graft to provide enhanced fixation and apposition to the aorta.
What is the current status of trial NCT06586021?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-02-06. Estimated completion is 2029-11-01.
What conditions does trial NCT06586021 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm (AAA).
What interventions are being tested in trial NCT06586021?
The interventions under investigation include: Aortoseal Endostapling System (DEVICE).
Who is sponsoring clinical trial NCT06586021?
This trial is sponsored by Endoron Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06586021 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abdominal Aortic Aneurysm (AAA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.